In 2004 Pedro graduated with a PhD from the laboratory of Mike Waterfield at UCL. He was also supervised by Robert Unwin, AL Burlingame and Rainer Cramer. After a postdoctoral position in Bart Vanhaesebroeck’s laboratory at the Ludwig Institute for Cancer Research, in 2007 Pedro obtained a lectureship at Barts Cancer Institute (part of Queen Mary University of London). There, he developed a programme of research in cell signalling and cancer biochemistry and in 2010 he was promoted to Senior Lecturer. After a ‘sabbatical’ year at MRC Clinical Sciences Centre in 2012, Pedro returned to Barts Cancer Institute in October 2013 where he now leads the Integrative Cell Signalling Group part of the Centre for Haemato-Oncology. Pedro’s latest research has involved the application of MS-based technology to rationalize responses of cancer cells to kinase inhibitors (MCP 2012, Genome Biology 2013, Science Signaling 2013). These proof-of-concept studies have shown that MS-based technology can be used to identify markers of responses of cancer cells to targeted inhibitors and can therefore contribute to advancing personalized cancer medicine.